A clinical perspective on ectopic Cushing's syndrome

Area of Science:

• Endocrinology
• Oncology
• Neurosurgery

Background:

• Cushing's syndrome (CS) results from prolonged pathological glucocorticoid excess.
• Ectopic Cushing's syndrome (ECS), caused by ACTH-producing tumors outside the pituitary, accounts for 10-20% of CS cases.
• Common sources of ectopic ACTH include bronchial neuroendocrine neoplasia (NEN), small cell lung cancer (SCLC), pancreatic NEN, thymic NEN, medullary thyroid cancer (MTC), and pheochromocytoma.

Purpose of the Study:

• To outline the diagnostic and management principles for ectopic Cushing's syndrome.
• To emphasize the importance of timely intervention in severe hypercortisolism due to ECS.
• To highlight the multidisciplinary approach required for optimal patient outcomes.

Main Methods:

• Review of clinical features and common etiologies of ectopic ACTH secretion.
• Discussion of diagnostic strategies including tumor localization techniques.
• Emphasis on therapeutic modalities for cortisol excess and tumor management.

Main Results:

• Patients with ECS often present with severe hypercortisolism, posing a high risk of life-threatening complications.
• Effective treatment of hypercortisolism is essential for improving patient outcomes.
• Successful management necessitates a methodical approach encompassing diagnosis, localization, cortisol control, and tumor resection.

Conclusions:

• Ectopic Cushing's syndrome requires a systematic approach for effective management.
• Early diagnosis and prompt treatment of hypercortisolism are critical for reducing morbidity and mortality.
• Surgical resection of the primary tumor, when feasible, is a key component of successful ECS treatment.